MS-STAT2 clinical drug trial open for recruitment

Person pouring pills into their hand

Aug 2018: MS-STAT2 is a UK-wide phase 3 clinical drug trial which will test simvastatin, a drug used to lower cholesterol, in people with secondary progressive MS (SPMS).

This phase 3 trial will establish definitively whether simvastatin is able to slow the rate of disability progression over a three year period in people with SPMS.

We hope to recruit 90 people from the Lothian area into the MS-STAT2 trial. The trial involves regular visits to the Anne Rowling Clinic to have neurological examinations, blood tests, walking distance tests and cognitive testing.

To find out more about the trial, please visit the MS-STAT2 project page.

This article was published on: Wednesday, August 01, 2018
×